Eyelid Tumor
6
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
17%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (6)
Telemedicine Follow-up for Routine, Low-Risk Oculoplastic Surgery
The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the Eyes
Dose-Modulated Sonidegib Therapy for Periocular Basal Cell Carcinoma
Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures
Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors
Mohs Surgery Combind With Cryotherapy for Eyelid Malignant Tumors.